You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Marburg Virus Prophylactic Medical Countermeasure

    SBC: Flow Pharma, Inc.            Topic: CBD18A002

    Through this STTR contract, we propose to evaluate the efficacy of our vaccine, FlowVax Marburg, in nonhuman primates (NHPs). This will be achieved through four Tasks. In Task 1, we will manufacture the vaccine in a quantity sufficient for the animal studies. In Task 2, we will perform MHC genotyping on a representative population of NHPs and, based on results, select a set of MHC-matched NHPs for ...

    STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense
  2. STTR Phase II: New Perfluorodioxolane- and Perfluorodioxane-based Copolymer Membranes for Gas Separations

    SBC: MEMBRANE TECHNOLOGY AND RESEARCH, INC.            Topic: CT

    The broader impact/commercial potential of this Small Business Technology Transfer Phase II project is to produce a better natural gas treatment membrane that will allow end users to capture the ease of processing and environmental advantages of membrane technology at a substantially reduced price. Natural gas processing to remove CO2 and other contaminants is the largest industrial gas separation ...

    STTR Phase II 2016 National Science Foundation
  3. STTR Phase II: A Novel Abdominal Stimulator to Assist with Ventilator Weaning in Patients

    SBC: LIBERATE MEDICAL LLC            Topic: BM

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase II project, in which a non-invasive respiratory muscle stimulation device and approach to weaning patients from mechanical ventilation will be developed, is a reduction in public health care expenditure and a reduction in morbidity for the half a million patients who have difficulty weaning from mechani ...

    STTR Phase II 2016 National Science Foundation
  4. STTR Phase I: Continuous Production and Collection of Magnesium via Carbothermal Reduction

    SBC: BIG BLUE TECHNOLOGIES LLC            Topic: MN

    This STTR Phase I project addresses the problem of embedded energy in the manufacture of magnesium metal for use in vehicle light-weighting. Improving fuel economy by incorporation of light metals, especially magnesium, does not save on total lifecycle energy consumed if the magnesium was produced using conventional methods. The most energy efficient production method known is a process technology ...

    STTR Phase I 2016 National Science Foundation
  5. STTR Phase I: User-Friendly Spirometer and Mobile App for Self-Management and Home Monitoring of Asthma Patients

    SBC: KNOX Medical Diagnostics Inc            Topic: BM

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project will close the gap between the hospital and home for proper asthma care. The greatest hurdles for proper lung assessment are costly devices ranging from $1000 to $30,000, and mandatory oversight from a skilled lab technician to ensure proper use. These hospital lung function tests allow for ea ...

    STTR Phase I 2016 National Science Foundation
  6. STTR Phase I: Novel Analysis Tools for Production of Higher Indican Yielding Plants for Bio-based Indigo

    SBC: STONY CREEK COLORS, INC.            Topic: CT

    The broader impacts of this Small Business Technology Transfer Phase I project relate to the increased viability of indigo as an agricultural crop competing with synthetically manufactured indigo dye. Indigo was among the major global cash crops of the 18th and 19th centuries and accounted for 100% of the indigo dye consumed in the world. Since the beginning of the 20th century, nearly 100% of the ...

    STTR Phase I 2016 National Science Foundation
  7. STTR Phase I: Advanced Computational System for Assessing Genetic Provenance in Crop Plants and its Practical Applications

    SBC: Prosapia Genetics LLC            Topic: BT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project will be the development of a highly accurate genotype analysis technique and the computational pipeline for assessing genetic provenance in crop plants. The commercial potential of the proposed products and services is based on the need to increase crop yield and accelerate breeding programs. The prop ...

    STTR Phase I 2016 National Science Foundation
  8. STTR Phase I: Sub-circuit Energy Monitoring and Performance ReAction Software (SEMPRA Software)

    SBC: Silicon Ribbon, LLC            Topic: EW

    The broader impact/commercial potential of this project centers on increasing the efficiency of computer power utilization even as transistors continue to shrink in size. The energy density requirements of modern computing devices are higher than ever before, leading to strict power constraints in mobile devices, high operating costs for fixed infrastructure computing, and incredibly low yields fo ...

    STTR Phase I 2016 National Science Foundation
  9. STTR Phase I: Biomanufacture of Novel Heparan Sulfate Glycosaminoglycans

    SBC: TEGA THERAPEUTICS INC            Topic: BT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project will be to commercialize novel sugar polymers known as glycosaminoglycan (GAGs) for a variety of important medical applications. GAGs are key components in a number of important physiologic and pathophysiologic conditions (e.g., tumor angiogenesis, thrombosis); however, developing a detailed understan ...

    STTR Phase I 2016 National Science Foundation
  10. Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications

    SBC: GENECAPTURE, INC.            Topic: CBD15C001

    The modern warfighter faces the constant threat of endemic infections, multi-drug resistant bacteria and Biological Warfare Agents. In order to provide accurate front-line treatment that will curtail the overuse of antibiotics, a rapid and robust molecula

    STTR Phase I 2016 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government